26 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
lowered CV events in T2DM ... lowered CV events in T2DM ... + T2DM; first renal ... with or without T2DM ... visualabstract #table
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Kidney Disease (CKD ... ml/min per 1.73 m2 ... ml/min per 1.73 m2 ... ml/min per 1.73 m2 ... • Stable SCr
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
#Diabetes #T2D ... #DM2 #Table #PrimaryCare
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
the dose of an ACEi ... Continue ACEi or ... patients with T2D ... ml/min per 1.73 m2 ... Insulin #metformin #ACEi
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
and Titration Algorithm ... Established ASCVD or CKD ... established ASCVD or CKD ... #Diabetes #DM2 ... Medication #Management #Algorithm
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Comorbidities: • Stable ... Dissection • CKD ... , DM, ESRD, PKD ... #pharmacology #table
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm ... Glycemic #Diabetes #DM2 ... Control #Medication #Algorithm
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... Improved outcomes in CKD ... #medications #table ... endocrinology #dm2
Causes of Polyneuropathy - Differential Diagnosis Algorithm
 • Metabolic: DM, Hypothyroidism, CKD, Cirrhosis, Nutritional deficiency
 •
Differential Diagnosis Algorithm ... • Metabolic: DM ... Hypothyroidism, CKD ... Paraneoplastic, CTD ... Differential #Diagnosis #Algorithm
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ACEI indicates angiotensin-converting ... angiotensin-receptor blocker; CAD ... resynchronization therapy; DM ... Stages #ACCAHA #Algorithm